Our global influence



Our global influence

Company

regenHU — a three dimensional biotechnology company, exploiting the potential of 3D bioprinting & cell based therapies — is leading the development of biomedical products for regenerative medicine & drug discovery. Based in Fribourg, Switzerland, regenHU is a pioneer and global leader in the field, converging digital manufacturing (3D printing), biomaterials and biotechnology to lead transformational innovations in Healthcare.

 

Value Proposition
regenHU provides leading-edge 3D bioprinting solutions. R&D teams worldwide purchase regenHU’s bioprinting platforms and biomaterials because they provide the greatest flexibility and precision for tissue engineering – such as bone, muscle, tendon, skin, kidney, liver and lung. regenHU enables therapies that are biologically and structurally tailored to each patient’s needs. Step-by-step, these breakthroughs are revolutionizing regenerative medicine, drug discovery and cosmeceutical development.Which healthcare breakthroughs do you want to accomplish?
Ask us how regenHU can help you make them happen!

We provide the tools to enter the
third dimension

PARTNERS ARCHIEVEMENTS


Our customers
our best references

001
002
003
004
005
006
007
008
009
010
011
012
013
014
015
016
017
018
019
020
021
022
023
024
025
026
027
028
029
030

 

…And many more

Award

In 2013, regenHU launched the “Young Scientist Award” which recognizes a personal contribution demonstrating a high degree of innovation and creativity in the field of regenerative medicine related to biofabrication technologies.

Introducing the “regenHU Young Scientist Award”

Biennial award to encourage/promote young Scientists in biofabrication 3’000 Euro cash price contribution to your project.
Open to Scientists under the age of 40 active in Academia, Industry, or starting a new scientific initiative in the field of biofabrication.
Applications in English presenting original works that contribute to the advancement of biofabrication. Research dissertations, project descriptions, or practical experience may be included.
The winner will be selected by an international jury of Scientists and Industry leaders.

Award Selection Committee

regenHU promotes scientific advancements that have the potential to bring a significant enhancement / tool to the healthcare world. Our mission is to create bridges between the scientific, academia and industrial environments “from the Lab to the Market”.

The distinguished selection committee was chosen based on the above philosophy, it comprises of 6 leaders with strong scientific and/or industrial backgrounds. The committee members are opinion leaders in the biofabrication environment either as user or as innovator.

Scientific Committee

Prof. Ernst Reichmann, PhD

Prof.   Ernst  Reichmann, PhDUniversity of Zürich, Switzerland

Prof. Daniel J. Kelly

Prof. Daniel J. KellyTrinity College Dublin, Ireland

Industrial Committee

Dr. Hansjoerg Keller

Dr. Hansjoerg KellerNovartis Institute for BioMedical Research
Basel, Switzerland

Dr. Paulo Marinho

Dr. Paulo MarinhoL’Oréal SA
Paris, France

Thurner Marc

Thurner MarcregenHU Ltd
Fribourg, Switzerland

Application dossier:

There is no template for the application dossier. Use your imagination and “feu sacré” to convince the above committee that your project/innovation will be a game changer in the healthcare world. Your dossier should contain at least the following:

Technical description of your PROJECT/INNOVATION and how it will impact the healthcare environment.
(PROJECT/INNOVATION is an on-going project, an idea for a project, or a vision)

Personal details and Academic record.
(Please add two letters of reference and letters of motivation)

Please submit your application dossier in digital form to award@regenHU.com before August 31, 2018.